Literature DB >> 23182217

Carbonic anhydrase binding site parameterization in OPLS-AA force field.

Guillaume Bernadat1, Claudiu T Supuran, Bogdan I Iorga.   

Abstract

The parameterization of carbonic anhydrase binding site in OPLS-AA force field was performed using quantum chemistry calculations. Both OH2 and OH(-) forms of the binding site were considered, showing important differences in terms of atomic partial charges. Three different parameterization protocols were used, and the results obtained highlighted the importance of including an extended binding site in the charge calculation. The force field parameters were subsequently validated using standard molecular dynamics simulations. The results presented in this work should greatly facilitate the use of molecular dynamics simulations for studying the carbonic anhydrase, and more generally, the metallo-enzymes.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23182217     DOI: 10.1016/j.bmc.2012.10.040

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Mutational analysis of the high-affinity zinc binding site validates a refined human dopamine transporter homology model.

Authors:  Thomas Stockner; Therese R Montgomery; Oliver Kudlacek; Rene Weissensteiner; Gerhard F Ecker; Michael Freissmuth; Harald H Sitte
Journal:  PLoS Comput Biol       Date:  2013-02-21       Impact factor: 4.475

2.  Mechanism of Action of Non-Synonymous Single Nucleotide Variations Associated with α-Carbonic Anhydrase II Deficiency.

Authors:  Taremekedzwa Allan Sanyanga; Bilal Nizami; Özlem Tastan Bishop
Journal:  Molecules       Date:  2019-11-04       Impact factor: 4.411

3.  Synthesis and biological evaluation of histamine Schiff bases as carbonic anhydrase I, II, IV, VII, and IX activators.

Authors:  Suleyman Akocak; Nabih Lolak; Daniela Vullo; Mustafa Durgun; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.